Corporate News M&A Snapshot: Johnson & Johnson to acquire Intra-Cellular Therapies in $14.6B CNS-focused deal by Contributor since / Followers 2 days ago Tags: JNJ Continue Reading Previous Caterpillar upgraded at Evercore ISI on pricing strategyNext Top-tier AI stocks remain profitable despite ‘choppy Fed backdrop’: Wedbush Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
